Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 1
1971 4
1972 3
1973 4
1974 6
1975 4
1976 2
1977 1
1978 4
1979 3
1980 2
1981 4
1982 8
1983 5
1984 7
1985 8
1986 6
1987 11
1988 11
1989 16
1990 30
1991 12
1992 15
1993 14
1994 1
1996 2
1997 1
1999 7
2000 5
2001 10
2002 17
2003 8
2004 16
2005 15
2006 12
2007 14
2008 7
2009 16
2010 17
2011 17
2012 15
2013 18
2014 21
2015 16
2016 11
2017 19
2018 16
2019 13
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

453 results
Results by year
Filters applied: . Clear all
Page 1
Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE. Solin LJ, et al. J Clin Oncol. 2015 Nov 20;33(33):3938-44. doi: 10.1200/JCO.2015.60.8588. Epub 2015 Sep 14. J Clin Oncol. 2015. PMID: 26371148 Free PMC article. Clinical Trial.
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
Vrieling C, van Werkhoven E, Maingon P, Poortmans P, Weltens C, Fourquet A, Schinagl D, Oei B, Rodenhuis CC, Horiot JC, Struikmans H, Van Limbergen E, Kirova Y, Elkhuizen P, Bongartz R, Miralbell R, Morgan DA, Dubois JB, Remouchamps V, Mirimanoff RO, Hart G, Collette S, Collette L, Bartelink H; European Organisation for Research and Treatment of Cancer, Radiation Oncology and Breast Cancer Groups. Vrieling C, et al. JAMA Oncol. 2017 Jan 1;3(1):42-48. doi: 10.1001/jamaoncol.2016.3031. JAMA Oncol. 2017. PMID: 27607734 Clinical Trial.
Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database.
Hwang KT, Kim EK, Jung SH, Lee ES, Kim SI, Lee S, Park HK, Kim J, Oh S, Kim YA; Korean Breast Cancer Society. Hwang KT, et al. Breast Cancer Res Treat. 2018 Jun;169(2):311-322. doi: 10.1007/s10549-018-4681-6. Epub 2018 Jan 30. Breast Cancer Res Treat. 2018. PMID: 29383628
Intraductal therapy of ductal carcinoma in situ: a presurgery study.
Mahoney ME, Gordon EJ, Rao JY, Jin Y, Hylton N, Love SM. Mahoney ME, et al. Clin Breast Cancer. 2013 Aug;13(4):280-6. doi: 10.1016/j.clbc.2013.02.002. Epub 2013 May 9. Clin Breast Cancer. 2013. PMID: 23664819 Free PMC article.
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Caviglia S, Avino F, Cortesi L, Taverniti C, Pacquola MG, Falcini F, Gulisano M, Digennaro M, Cariello A, Cagossi K, Pinotti G, Lazzeroni M, Serrano D, Branchi D, Campora S, Petrera M, Buttiron Webber T, Boni L, Bonanni B. DeCensi A, et al. J Clin Oncol. 2019 Jul 1;37(19):1629-1637. doi: 10.1200/JCO.18.01779. Epub 2019 Apr 11. J Clin Oncol. 2019. PMID: 30973790 Free PMC article. Clinical Trial.
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R, Liew SH, Connelly AA, Yee NS, Deb S, Kumar B, Vargas AC, O'Toole SA, Parslow AC, Poh A, Putoczki T, Morrow RJ, Alorro M, Lazarus KA, Yeap EFW, Walton KL, Harrison CA, Hannan NJ, George AJ, Clyne CD, Ernst M, Allen AM, Chand AL. Coulson R, et al. Oncotarget. 2017 Mar 21;8(12):18640-18656. doi: 10.18632/oncotarget.15553. Oncotarget. 2017. PMID: 28416734 Free PMC article.
Clinical Trials for Ductal Carcinoma In Situ of the Breast.
Han MS, Khan SA. Han MS, et al. J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):293-301. doi: 10.1007/s10911-018-9413-3. Epub 2018 Sep 11. J Mammary Gland Biol Neoplasia. 2018. PMID: 30206737 Review.
453 results
Jump to page
Feedback